The Effect of Upper Limb Low-intensity Motor Control Training Program on Cognitive Function in Healthy Older Adults
Trial Parameters
Brief Summary
This healthy volunteer intervention study is designed to evaluate the effectiveness of upper limb motor control training (uMCT) on physical and cognitive functions in older adults. The primary objectives of the study are twofold: Assess the Impact on Physical and Neuromuscular Function: The study seeks to determine whether uMCT positively influences physical performance, including motor coordination and neuromuscular function, in older adults. Assessment the Impact on Cognitive Function: The study aims to investigate whether uMCT enhances cognitive abilities in older adults. In addition to these main goals, the study will also assess the feasibility and safety of implementing uMCT in an older adult population. The main questions it aims to answer are: Does uMCON training have a positive effect on physical function and neuromuscular function in older adults? Does uMCON training have a positive effect on cognitive function in older adults? The researchers designed this study to show whether uMCON training works on physical function (balance, gait, and so on) and cognition in older adults. Participants will come to Derby Royal Hospital Medical School to attend uMCON training three days a week for 1 month. They will attend pre-training, post-training, and follow-up (after 1 month) control assessment sessions.
Eligibility Criteria
Inclusion Criteria: * • Willing and able to give informed consent for participation in the study * Aged between 65-85 years Exclusion Criteria: * • Diagnosis of cognitive impairment * Current or recent (\<5y) malignancy * History of or current psychiatric illness * History of or current neurological condition (e.g., epilepsy, Parkinsons disease, cerebrovascular disease) * Severe respiratory disease (e.g., uncontrolled asthma, COPD, pulmonary hypertension) * Active cardiovascular disease: Uncontrolled hypertension (BP\>160/100mmHg); Recent (\<12mo) cardiac event; Heart failure (Class III/IV); Significant arrhythmia; Unstable angina * Metabolic disease: Untreated hyper/hypo-parathyroidism; Cushing's disease; Type 1 or 2 diabetes * Significant musculoskeletal disorders (based on clinical opinion) * Family history of early (\<55y) death from cardiovascular disease